А. Л. Хохлов
Yaroslavl State Medical Academy · 201 works · 2,431 citations · h-index 10
Top works
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
- Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee
- Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study
- Ethical aspects of using software with artificial intelligence technology
- Risks associated with the ethical aspects of conducting clinical trials
- Efficacy and safety of flavocoxid compared with naproxen in subjects with osteoarthritis of the knee— a subset analysis
- The concept of patient-oriented medicine and pharmacy
- Pharmacoeconomic and pharmacogenetic aspects of the implementation of a personalized approach in the treatment of cardiac patients
- Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
- The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169)
- Temporary pain relief using transcranial electrotherapy stimulation: results of a randomized, double-blind pilot study
- Ethical aspects of the Internet of Bodies
- SILVER NANOPARTICLES IN THE SOLUTION OF THE PROBLEM OF DRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
- Development of quantification methods of a new selective carbonic anhydrase II inhibitor in plasma and blood and study of the pharmacokinetics of its ophthalmic suspension in rats
- Antimicrobial Dispensing Practice in Community Pharmacies in Russia during the COVID-19 Pandemic
- X-ray contrast media: focus on safety
- PHARMACOGENETIC FEATURES OF THERAPY OF PATIENTS WITH ATHEROSCLEROSIS
- Identification and synthesis of metabolites of the new 4.5-dihydroisoxazol-5-carboxamide derivate
- Ethical issues of using artificial intelligence in drug development